Alkem Laboratories informs about sale of St. Louis manufacturing facility

30 Dec 2023 Evaluate
Alkem Laboratories has informed that as part of the Company’s operational strategy, the operations of the Company carried out at the St. Louis manufacturing facility situated in USA owned by S&B Pharma LLC, a step-down subsidiary of the Company, (Facility) are closed. Accordingly, all rights, title and interest in the land, improvements and personal property with respect to the said Facility owned by S&B Pharma LLC, a step-down subsidiary of the Company in USA (Seller) are sold to New Mill Capital Holdings LLC (Buyer) pursuant to the ‘Purchase and Sale Agreement’ executed between the Buyer and Seller. The details as required under SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 are enclosed as Annexure I.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5431.85 -65.55 (-1.19%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.